Found 10 matching trials
The Survey of Ipragliflozin Treatment in Elderly type2 Diabetes Patients N/A The objective of this survey is to confirm the safety of Suglat Tablets whe...
Show More Location
Multiple Locations
Learn More & Join Trial
Metabolic and Cardiovascular Effects of Dipeptidyl Peptidase-4 (DPP-4) or Sodium-glucose Co-transporter Type 2 (SGLT2) Inhibitors PHASE4 Inhibition of dipeptidyl peptidase-4 (DPP-4) or sodium-glucose co-transport...
Show More Location
Kurume University Hospital
Learn More & Join Trial
Investigation for Clinical Efficacy and Safety of Ipragliflozin 50mg and 100mg on Type II Diabetes N/A The purpose of this study is to evaluate clinical efficacy and safety of So...
Show More Location
Osaka Saiseikai Nakatsu Hospital
Learn More & Join Trial
Meta-analysis in Post-marketing Surveillances for SGLT2 Inhibitors in Patients With Type 2 Diabetes Mellitus N/A The purpose of this study is to integrate the post-marketing surveillances ...
Show More Location
Multiple Locations
Learn More & Join Trial
Specified Drug Use Results Survey of Ipragliflozin Treatment in type2 Diabetes Patients N/A The objective of this survey is to confirm the safety of Suglat Tablets...
Location
Multiple Locations
Learn More & Join Trial
SGLT2 Inhibitors on Clinical Outcomes and Left Ventricular Remodeling in Type 2 Diabetic Patients with Acute Myocardial Infarction, a Prospective, Multi-center Registry Study N/A Prospective trials performed on type 2 diabetes patients without establishe...
Show More Location
Seoul St. Mary's Hospital
Learn More & Join Trial
Study of Ipragliflozin in Patients With Type 2 Diabetes Mellitus Receiving Insulin Therapy PHASE4 The objective of this study is to assess the reduction in insulin dose from...
Show More Learn More & Join Trial
Pharmacodynamics, Pharmacokinetics, and Safety of ASP1941 in Patients With Type 1 Diabetes Mellitus PHASE2 The objective of this study is to assess pharmacodynamics, pharmacokinetics...
Show More Learn More & Join Trial
A Study of ASP1941 in Combination With Insulin in Patients With Type 1 Diabetes Mellitus PHASE3 The objective of this study is to confirm efficacy of ASP1941 based on the ...
Show More Learn More & Join Trial
A Study to Assess the Efficacy and Safety of Ipragliflozin in Combination With Insulin in Subjects With Type 2 Diabetes Mellitus PHASE4 The purpose of this study is to assess the efficacy (superiority to placebo...
Show More Location
Multiple Locations
Learn More & Join Trial